• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麦角硫因的6-杂环羧酸酯衍生物可产生胃癌细胞中的赖氨酸特异性去甲基化酶1(LSD1)抑制剂。

6-Heterocyclic carboxylic ester derivatives of gliotoxin lead to LSD1 inhibitors in gastric cancer cells.

作者信息

Shan Lihong, Li Zhaoxiang, Chen Huabin, Ge Meng, Sun Yingying, Sun Ying, Li Yaru, Li Hongyu, Fu Ling, Liu Hongmin

机构信息

School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou 450001, China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou 450001, China.

School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.

出版信息

Bioorg Chem. 2023 Feb;131:106150. doi: 10.1016/j.bioorg.2022.106150. Epub 2022 Sep 13.

DOI:10.1016/j.bioorg.2022.106150
PMID:36508940
Abstract

Gliotoxin is a representative compound of the epipolythiodioxopiperazine (ETP) class of fungal metabolites. Histone Lysine Specific Demethylase 1 (LSD1) is highly expressed in a variety of cancers. Herein, a series of 6-heterocyclic carboxylic ester derivatives of gliotoxin was designed and synthesized as new LSD1 inhibitors and their biological evaluations in human gastric MGC-803 and HGC-27 cells were carried out. All of the derivatives effectively suppressed the enzymatic activities of LSD1. In particular, compound 4e exhibited excellent LSD1 inhibition with IC = 62.40 nM, as well as anti-proliferation against MGC-803 and HGC-27 cells with IC values of 0.31 μM and 0.29 μM, respectively. 4e also had a remarkable capacity to inhibit the colony formation, suppress migration and induce the apoptosis of these two cancer cell lines. In sum, our findings identified and characterized the 6-heterocyclic carboxylic ester derivatives of gliotoxin as potent and cellular active LSD1 inhibitors, which may provide a novel chemotype of LSD1 inhibitors for gastric cancer treatment.

摘要

Gliotoxin是真菌代谢产物中表硫代二氧哌嗪(ETP)类的代表性化合物。组蛋白赖氨酸特异性去甲基化酶1(LSD1)在多种癌症中高表达。在此,设计并合成了一系列gliotoxin的6-杂环羧酸酯衍生物作为新型LSD1抑制剂,并在人胃癌MGC-803和HGC-27细胞中进行了生物学评价。所有衍生物均有效抑制LSD1的酶活性。特别是,化合物4e表现出优异的LSD1抑制活性,IC50 = 62.40 nM,对MGC-803和HGC-27细胞的抗增殖IC50值分别为0.31 μM和0.29 μM。4e还具有显著的抑制这两种癌细胞系集落形成、抑制迁移和诱导凋亡的能力。总之,我们的研究结果鉴定并表征了gliotoxin的6-杂环羧酸酯衍生物为有效的细胞活性LSD1抑制剂,这可能为胃癌治疗提供一种新型的LSD1抑制剂化学类型。

相似文献

1
6-Heterocyclic carboxylic ester derivatives of gliotoxin lead to LSD1 inhibitors in gastric cancer cells.麦角硫因的6-杂环羧酸酯衍生物可产生胃癌细胞中的赖氨酸特异性去甲基化酶1(LSD1)抑制剂。
Bioorg Chem. 2023 Feb;131:106150. doi: 10.1016/j.bioorg.2022.106150. Epub 2022 Sep 13.
2
Discovery of novel tranylcypromine-based derivatives as LSD1 inhibitors for gastric cancer treatment.发现新型曲奈普汀类衍生物作为治疗胃癌的 LSD1 抑制剂。
Eur J Med Chem. 2023 May 5;251:115228. doi: 10.1016/j.ejmech.2023.115228. Epub 2023 Feb 23.
3
Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer.新型赖氨酸特异性去甲基酶 1(LSD1)和组蛋白去乙酰化酶(HDAC)双重抑制剂的设计、合成及生物评价用于胃癌治疗。
Eur J Med Chem. 2021 Aug 5;220:113453. doi: 10.1016/j.ejmech.2021.113453. Epub 2021 Apr 25.
4
Discovery of novel N-benzylarylamide-dithiocarbamate based derivatives as dual inhibitors of tubulin polymerization and LSD1 that inhibit gastric cancers.发现新型 N-苄基芳酰胺-二硫代氨基甲酸盐类衍生物作为微管聚合和 LSD1 的双重抑制剂,能够抑制胃癌。
Eur J Med Chem. 2023 Apr 5;252:115281. doi: 10.1016/j.ejmech.2023.115281. Epub 2023 Mar 16.
5
Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.基于三氮唑-二硫代氨基甲酸盐的赖氨酸特异性去甲基化酶 1(LSD1)选择性抑制剂抑制胃癌细胞生长、侵袭和迁移。
J Med Chem. 2013 Nov 14;56(21):8543-60. doi: 10.1021/jm401002r. Epub 2013 Nov 1.
6
Discovery of quinazoline derivatives as a novel class of potent and in vivo efficacious LSD1 inhibitors by drug repurposing.通过药物再利用发现喹唑啉衍生物作为一类新型强效且体内有效的赖氨酸特异性去甲基化酶1(LSD1)抑制剂。
Eur J Med Chem. 2021 Dec 5;225:113778. doi: 10.1016/j.ejmech.2021.113778. Epub 2021 Aug 14.
7
Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors.设计、合成及新型苯并呋喃衍生物的生物评价作为潜在 LSD1 抑制剂。
Eur J Med Chem. 2021 Aug 5;220:113501. doi: 10.1016/j.ejmech.2021.113501. Epub 2021 Apr 24.
8
Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening.基于药效团和结构的虚拟筛选鉴定组蛋白赖氨酸特异性去甲基酶 1(LSD1)的新型抑制剂。
J Biomol Struct Dyn. 2019 Oct;37(16):4200-4214. doi: 10.1080/07391102.2018.1538903. Epub 2018 Dec 5.
9
Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells.基于吩噻嗪的 LSD1 抑制剂促进胃癌细胞的 T 细胞杀伤反应。
J Med Chem. 2023 Mar 23;66(6):3896-3916. doi: 10.1021/acs.jmedchem.2c01593. Epub 2023 Mar 1.
10
Discovery of 2-Aryl-4-aminoquinazolin-Based LSD1 Inhibitors to Activate Immune Response in Gastric Cancer.发现基于 2-芳基-4-氨基喹唑啉的 LSD1 抑制剂可激活胃癌中的免疫反应。
J Med Chem. 2024 Sep 26;67(18):16165-16184. doi: 10.1021/acs.jmedchem.4c00972. Epub 2024 Sep 12.